期刊文献+

Immunological dynamics in response to two anthrax vaccines in mice

Immunological dynamics in response to two anthrax vaccines in mice
原文传递
导出
摘要 In order to understand the variation of humoral and cellular immune responses to A16R live spore and AVA vaccine and to identify efficient immunological parameters for the early evaluation of post immu- nization in mice, we dynamically monitored the antibody production and cellular responses after the vaccination of Balb/C mice with the anthrax vaccines. The results show that both anti-AVA and anti-Spore antibodies were detectable in the A16R live spore vaccinated group while high titers of anti-AVA antibodies but not anti-Spore antibodies existed in the AVA-immunized group. IgG1 and IgG2 were the major subtypes of IgG in both of the two groups. However, the IgG2a level was significantly higher in the A16R group than in the AVA group. At the cellular level, responses of antigen-specific TH2, TH1 and plasma cells were detected. The peripheral TH2 responses could be seen on day 5 after vac- cination, and remained at a high level throughout the experiment (from day 5 post primary immuniza- tion to day 60 post the tertiary immunization); the TH1 responses to A16R vaccine appeared on day 5, while the responses to AVA could only be detected by day 7 after the secondary immunization; a low level of TH1 responses could be observed at the end of the experiment. Antigen-specific plasma cells could be found in the peripheral blood of both the immunized groups, however, the responses in the A16R group appeared earlier, lasted longer, and shown an ascending tendency until the end of the ex- periment when the plasma cell responses in the AVA group were reduced to a very low level. The re- sults suggest that the multiple antigen containing A16R live spore vaccine induces better immune re- sponses than AVA. Combined with serum antibody titers, TH2, TH1 and plasma cell responses could be used as immunological parameters for the evaluation of vaccine efficacy. These findings may afford new insight into the early evaluation of vaccination as well as being a powerful strategy for vaccine development. In order to understand the variation of humoral and cellular immune responses to A16R live spore and AVA vaccine and to identify efficient immunological parameters for the early evaluation of post immu- nization in mice, we dynamically monitored the antibody production and cellular responses after the vaccination of Balb/C mice with the anthrax vaccines. The results show that both anti-AVA and anti-Spore antibodies were detectable in the A16R live spore vaccinated group while high titers of anti-AVA antibodies but not anti-Spore antibodies existed in the AVA-immunized group. IgG1 and IgG2 were the major subtypes of IgG in both of the two groups. However, the IgG2a level was significantly higher in the A16R group than in the AVA group. At the cellular level, responses of antigen-specific TH2, TH1 and plasma cells were detected. The peripheral TH2 responses could be seen on day 5 after vac- cination, and remained at a high level throughout the experiment (from day 5 post primary immuniza- tion to day 60 post the tertiary immunization); the TH1 responses to A16R vaccine appeared on day 5, while the responses to AVA could only be detected by day 7 after the secondary immunization; a low level of TH1 responses could be observed at the end of the experiment. Antigen-specific plasma cells could be found in the peripheral blood of both the immunized groups, however, the responses in the A16R group appeared earlier, lasted longer, and shown an ascending tendency until the end of the ex- periment when the plasma cell responses in the AVA group were reduced to a very low level. The re- sults suggest that the multiple antigen containing A16R live spore vaccine induces better immune re- sponses than AVA. Combined with serum antibody titers, TH2, TH1 and plasma cell responses could be used as immunological parameters for the evaluation of vaccine efficacy. These findings may afford new insight into the early evaluation of vaccination as well as being a powerful strategy for vaccine development.
出处 《Science China(Life Sciences)》 SCIE CAS 2008年第10期872-878,共7页 中国科学(生命科学英文版)
关键词 ANTHRAX VACCINE adsorbed live SPORE VACCINE antigen secreting cells IMMUNOLOGICAL RESPONSE ELISPOT anthrax vaccine adsorbed, live spore vaccine, antigen secreting cells, immunological response, ELISPOT
  • 相关文献

参考文献20

  • 1Corbin G A,Harty J T.T cells undergo rapid ON/OFF but not ON/OFF/ON cycling of cytokine production in response to antigen. J Immunol . 2005
  • 2Odendahl M,Mei H,Hoyer BF,et al.Generation of migratory anti-gen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood . 2005
  • 3Crotty S,Aubert R D,Glidewell J,et al.Tracking human anti-gen-specific memory B cells:A sensitive and generalized ELISPOT system. Journal of Immunological Methods . 2004
  • 4Crotty S,Felgner P,Davies H,et al.Cutting edge:long-term B cell memory in humans after smallpox vaccination. J Immunol . 2003
  • 5Kvarnstr?m M,Jenmalm M C,Ekerfelt C.Effect of cryopreservation on expression of Th1and Th2cytokines in blood mononuclear cells from patients with different cytokine profiles,analysed with three common assays:An overall decrease of interleukin-4. Cryobiology . 2004
  • 6Whitmire J K,Asano M S,Murali-Krishna K,et al.Long term CD4Th1and Th2memory following acute lymphocytic choriomeningitis virus infection. Journal of Virology . 1998
  • 7Mosmann T R,,Cherwinski H,Bond M W,et al.Two types of murine helper T cell clone.I.Definition according to profiles of lymphokine activities and secreted proteins.1986. J Immunol . 2005
  • 8Jelley-Gibbs D M,Strutt T M,McKinstry K K,et al.Influencing the fates of CD4T cells on the path to memory:Lessons from influenza. Immunology and Cell Biology . 2008
  • 9Fazilleau N,McHeyzer-Williams L J,McHeyzer-Williams M G.Local development of effector and memory T helper cells. Current Opinion in Immunology . 2007
  • 10Pittman P R,Kim-Ahn G,Pifat D Y,et al.anthrax vaccine:immu-nogenicity and safety of a dose-reduction,route-change comparison study in humans. Vaccine . 2002

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部